Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cupping Therapy and SERKANGABIN Versus Conventional Treatment of Migraine Headache: a Randomized Controlled Trial

NCT01476930 is registered in ClinicalTrials.gov with Birjand University of Medical Sciences as lead sponsor.

NCT NCT01476930
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01476930 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cupping Therapy and SERKANGABIN Versus Conventional Treatment of Migraine Headache: a Randomized Controlled Trial
Lead sponsor
Birjand University of Medical Sciences
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2008
Completion date
October 31, 2011
Enrollment
391 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

migraine headache